Neoadjuvant chemotherapy as ovarian cancer treatment: ever more used with major regional differences

Carsten L Fagö-Olsen, Bent Ottesen, Henrik Kehlet, Algirdas Markauskas, Berit J Mosgaard, Christian Ottosen, Charlotte Søgaard, Erik Søgaard-Andersen, Claus Høgdall

10 Citationer (Scopus)

Abstract

The traditional first-line treatment for patients with advanced ovarian cancer with primary debulking surgery (PDS) and adjuvant chemotherapy is controversial as some authors report a potential benefit from the alternative treatment with neoadjuvant chemotherapy (NACT) and interval debulking surgery. The aim of this study was to investigate the use of NACT in Denmark in regard to increased use and regional differences.
OriginalsprogEngelsk
TidsskriftDanish Medical Journal
Vol/bind59
Udgave nummer8
Sider (fra-til)A4477
Antal sider5
StatusUdgivet - 2012

Fingeraftryk

Dyk ned i forskningsemnerne om 'Neoadjuvant chemotherapy as ovarian cancer treatment: ever more used with major regional differences'. Sammen danner de et unikt fingeraftryk.

Citationsformater